p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice
1Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446,
2Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea
Tel: +82-2-961-9377, Fax: +82-2-961-9580
Received: February 15, 2022; Revised: May 6, 2022; Accepted: May 13, 2022; Published online: July 5, 2022.
© The Korean Society of Applied Pharmacology. All rights reserved.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/
) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.